CD9 and colorectal cancer: developed “ExoScreen,” an analytical technique for early detection of colorectal cancer, based on the fact that from raw blood samples from patients, EVs are trapped by CD147 (colorectal cancer‐specific antibody) and CD9 (exosomal membrane marker), and detected by photosensitizing beads.